Option Chain

MoonLake Immunotherapeutics

MLTXNASDAQ · USD

13.38USD+0.83 (+6.62%)

122

MoonLake Immunotherapeutics (MLTX) Option Chain

As of September 21, 2026, MoonLake Immunotherapeutics is trading at $13.38, a +6.62% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 68.9%. IV Rank is 6%.

Tracking the MLTX option chain helps you see every strike and expiry on MoonLake Immunotherapeutics in one view, so you can quickly identify the contracts that fit your thesis and your risk. MoonLake Immunotherapeutics's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of MLTX options activity at a glance. Use our scanner to monitor the MLTX option chain in real time and filter for the MLTX options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For MLTX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the MLTX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where MLTX stock options are being actively traded and where they are not.

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls MoonLake Immunotherapeutics's full chain across every expiry, highlights the most liquid strikes, and lets you screen MLTX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of MLTX stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

IndustryBiotechnology
SectorHealthcare
IV percentile46.43% Neutral
Market cap (M$)1,068
52 weeks high-80.00%
52 weeks low110.92%
Analyst recommendationBuy
1.80
Target price$30.38
127.06% above the current stock price
Dividend—
Payout ratio—
Earnings date2026-11-04
P/E—
Future P/E—
EPS (ttm)-3.84
EPS growth next 5 years9.01%

As of September 21, 2026

CALLs									PUTs
Prob. OTM %	Open Interest	Volume	Extrinsic Value	Intrinsic Value	Bid	Ask	Strike	Moneyness %	Bid	Ask	Intrinsic Value	Extrinsic Value	Volume	Open Interest	Prob. OTM %
25.45	0	0	-0.53	2.38	1.15	2.55	11.00	-12.35	—	0.60	0.00	0.60	0	0	74.55
43.04	6	0	-0.28	1.38	0.90	1.30	12.00	-4.38	0.10	0.95	0.00	0.53	0	61	56.96
60.68	24	1,509	0.27	0.38	0.55	0.75	13.00	+3.59	0.90	1.15	0.00	1.03	12	10	39.32
75.31	312	30	0.30	0.00	0.25	0.35	14.00	+11.55	0.50	3.30	0.62	1.28	0	26	24.69
85.75	120	327	0.25	0.00	0.10	0.40	15.00	+19.52	2.30	3.30	1.62	1.18	1	81	14.25

As of September 21, 2026

Browse all Option Chain tickers

Stock Statistics

Scan the full option chain in one place